753 Companies

Access all companies

Find technology partners quickly.

Spotfolio tracks over one million companies in technology industries.

There are 753 companies in the field of Biopharma on spotfolio that produce or deliver products, that utilize or research technologies or that are otherwise engaged in topics such as Clinical, Drug, Therapeutic, Patients, Oncology, Therapies, Disease, Research .

Start-ups (99)

Early-stage companies (221)

Established companies (389)

The majority of these companies is located in the following countries.

United States (411)

United Kingdom (53)

China (35)

Canada (33)

Example Companies

Find companies in your area

Kura Oncology Kura Oncology, Inc.

early-stage

Access

  • Technologies
  • Core data such as location, employees, revenues
  • Similar and peer companies
  • and more

Web Quotes

August 2020. Dr. Dale is a recognized R&D leader with expertise in oncology and immuno-oncology across both early and late-stage clinical development. As Global ...

including Oncology, Neuroscience, Immunology and Rare Diseases, and was a significant contributor to both FDA and EMA approvals in oncology and neurosciences ...

AstraZeneca, most recently as Global Clinical Vice President and Clinical Head of Oncology – GMed, where he oversaw the development of Tagrisso® (osimertinib) for ...

is not provided by Kura Oncology but by a third party and is not intended to be relied on for investment purposes. Kura Oncology does not guarantee the ...

is not provided by Kura Oncology but by a third party and is not intended to be relied on for investment purposes. Kura Oncology does not guarantee the ...

is not provided by Kura Oncology but by a third party and is not intended to be relied on for investment purposes. Kura Oncology does not guarantee the

FUNCTIONS: - Lead cross-functional clinical teams for the design and conduct of oncology/hematology studies. - Ensure that scientific rigor and innovation continues ...

partner with others to implement innovative oncology development strategies. - Experience in precision oncology/hematology preferred. WORK ENVIRONMENT: ...

weekend and overtime duties may be required as assigned by the manager. Kura Oncology is an Equal Opportunity Employer that offers a competitive and comprehensive ...

is not provided by Kura Oncology but by a third party and is not intended to be relied on for investment purposes. Kura Oncology does not guarantee the ...

is not provided by Kura Oncology but by a third party and is not intended to be relied on for investment purposes. Kura Oncology does not guarantee the ...

is not provided by Kura Oncology but by a third party and is not intended to be relied on for investment purposes. Kura Oncology does not guarantee the

ALX Oncology ALX Oncology Limited

early-stage

Access

  • Technologies
  • Core data such as location, employees, revenues
  • Similar and peer companies
  • and more

Web Quotes

to Apply - Investors - Contact News Release Details ALX Oncology Names Leading Oncology Experts to Scientific Advisory Board PDF Version BURLINGAME ...

(GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or the “Company”) (Nasdaq: ALXO) a clinical-stage immuno-oncology company developing therapies ...

formation of the Company's Scientific Advisory Board (“SAB”) with three leading oncology experts. The SAB will provide valuable strategic and scientific counsel ...

experts in oncology to our scientific advisory board,” said Jaume Pons, Ph.D., Founder, President and Chief Executive Officer of ALX Oncology. “These advisors ...

across multiple oncology indications.” “It is a privilege to work with a talented group of renowned oncology experts to assist ALX Oncology in developing ...

significant impact on people who are fighting cancer.” The members of the ALX Oncology SAB include: - Keith Flaherty, M.D. (Chair) - Dr. Flaherty is a Professor

ALX Oncology to Present ALX148 Clinical Data at the 62nd American Society of Hematology (ASH) Annual Meeting Read more Nov 2, 2020 ALX Oncology Announces ...

Virtual Investor Conference Participation Read more Oct 28, 2020 ALX Oncology Announces First Patient Dosed in ASPEN-02, a Phase 1/2 Study of ALX148 ...

in Patients with Myelodysplastic Syndrome Read more Oct 14, 2020 ALX Oncology to Present ALX148 Clinical Data at the Society for Immunotherapy of Cancer ...

more Oct 6, 2020 ALX Oncology Names Leading Oncology Experts to Scientific Advisory Board Read more Sep 22, 2020 ALX Oncology to Collaborate with Merck ...

Merck on Phase 2 Immuno-Oncology Studies Evaluating ALX148, Targeting CD47, in Combination with KEYTRUDA® (pembrolizumab) in Patients with Head & Neck Cancer ...

Cancer Read more Sep 17, 2020 ALX Oncology Added to Russell 2000® and 3000® Indexes Read more Sep 8, 2020 ALX Oncology Announces Participation at Upcoming

Takeda Oncology

established

Access

  • Technologies
  • Core data such as location, employees, revenues
  • Similar and peer companies
  • and more

Web Quotes

Investigational Drugs - PARTNERSHIPS - Partnering with Takeda Oncology - Grants & Donations ABOUT TAKEDA ONCOLOGY - Our Commitment - People & Culture - Policies & ...

Culture OUR PEOPLE AND CULTURE With more than 1,300 people dedicated to oncology, our people and culture are an integral part of our long-term success. ...

and aspiration. GLOBAL ONCOLOGY LEADERSHIP TEAM Comprised of Takeda's global oncology commercial operations, Takeda Oncology operates in close alignment ...

alignment with Takeda's dedicated global oncology R&D function, the Oncology Therapeutic Area Unit (OTAU), to drive forward the company's products while maintaining ...

maintaining a focus on expanding our oncology pipeline. The organizational structure and governance model for Takeda Oncology is designed to drive customer proximity ...

nimbleness, agility and accountability. Consistent with these principles, Takeda Oncology operates with a relatively flat organization that allows close proximity

PARTNERSHIPS - Partnering with Takeda Oncology - Grants & Donations OUR PARTNERSHIPS - Partnering with Takeda Oncology - Grants & Donations PARTNERSHIPS ...

PARTNERSHIPS / Grants & Donations GRANTS & DONATIONS Takeda Oncology knows that achieving our aspiration to cure cancer will take time, hard work and dedicated ...

their patients. Through educational grants and charitable donations, Takeda Oncology provides education and support to healthcare professionals, patients, caregivers ...

making improvements in patient care. Educational Grant Requests Takeda Oncology considers educational grant requests for both accredited and non-accredited ...

laws and guidance. Scientific & Professional Development Grants Takeda Oncology supports programs that offer scientific and developmental activities including ...

for independent third-party educational or professional meetings. Takeda Oncology reviews grant requests across multiple disease areas; however, priority

Oncology Venture

early-stage

Access

  • Technologies
  • Core data such as location, employees, revenues
  • Similar and peer companies
  • and more

Web Quotes

Oncology Venture A/S Venlighedsvej 1, DK-2970 Hoersholm CVR no. DK 28 10 63 51 Årsredovisning 2018 Oncology Venture A/S Innehåll Bolagsinformation ...

rapport Oncology Venture A/S, CVR-nummer DK 28 10 63 51 Den 30 maj 2018 bytte bolaget namn från Medical Prognosis Institute A/S till Oncology Venture A/S ...

A/S. Oncology Venture A/S och Oncology Venture Sweden AB slogs samman den 21 augusti 2018 som Oncology Venture A/S CVR-nummer DK 28 10 63 51, noterat på ...

Stockholm. Oncology Venture Sweden AB, organisationsnummer 559016-3290 Den 31 augusti 2018 avnoterades bolaget från Spotlight Stock Market. 2 Oncology Venture ...

Venture A/S Bolagsinformation osv Bolaget Oncology Venture A/S Venlighedsvej 1 DK-2970 Hoersholm CVR-nr: DK 28 10 63 51 Styrelse Duncan Moore, styrelseordförande ...

31 3 Oncology Venture A/S Förvaltningsberättelse VD HAR ORDET Under 2018 tog vi flera strategiskt viktiga steg för att positionera Oncology Venture

Oncology Venture A/S Venlighedsvej 1, DK-2970 Hørsholm CVR no. DK 28 10 63 51 Delårsrapport för perioden 1 januari – 30 juni 2019 Oncology Venture A/S ...

Moderbolagets förändringar i eget kapital Koncernens noter 22 - 23 24 25 - 32 2 Oncology Venture A/S Utlåtande från styrelse och ledning Styrelsen och ledningen ...

Magnus Persson Carani Sanjeevi Styrelseordförande Steen Meier Knudsen 3 Oncology Venture A/S Förvaltningsberättelse UTVALD FINANSIELL INFORMATION OCH ...

definitioner, se redovisningsprinciper i årsredovisningen för år 2018 4 Oncology Venture A/S Förvaltningsberättelse VÄSENTLIGA HÄNDELSER UNDER Q2 2019 ...

juni meddelade det europeiska patentverket (EPO) att man kommer bevilja Oncology Venture ett patent för LiPlaCis DRP®, ett prediktionsverktyg som täcker ...

patienter kommer svara på behandling med LiPlaCis®. Den 13 juni förvärvade Oncology Venture ytterligare 8% ägande i dovitinib-projektet från Sass & Larsen

QUE Oncology

early-stage

Access

  • Technologies
  • Core data such as location, employees, revenues
  • Similar and peer companies
  • and more

Web Quotes

LATEST NEWS THE PRESS - FRONT PAGE "Australian biotechnology company Que Oncology to treat hot flushes in women receiving hormone therapy." NEW ZEALAND ...

cancer survivors asked to keep diary of hot flushes for new drug trial QUE ONCOLOGY LAUNCHED PHASE II TRIALS IN NEW ZEALAND "Biotech creating a new therapy ...

" QUE ONCOLOGY APPOINTS TWO NEW BOARD OF DIRECTORS Dr. Julie Cherrington and Elizabeth Cermak have been appointed to the board, QUE ONCOLOGY LAUNCHED ...

could be tackled by a new drug to go on trail around Australia..." QUE ONCOLOGY LAUNCHED PHASE II TRIALS Biotech creating a new therapy for hot flushes ...

trials across Australia. FINANCIAL REVIEW UQ breast cancer drug maker QUE Oncology raises $21.5m from Medical Research Commercialisation Fund

TEAM Rob Crombie, PhD Dr Rob Crombie, Chief Executive Officer of Que Oncology, has over 20 years of background in private and public markets in the UK ...

David Moskovic, MBA David Moskovic, Director of Clinical Operations at Que Oncology has over 20 years of clinical research experience in project management ...

strategic development, and drug development. Dave has extensive experience in oncology studies including supportive care studies as well as various complex disease ...

disease indications and orphan drug indications. Prior to joining QUE Oncology, he worked in various clinical project management roles in the CRO industry ...

oversaw clinical development programs in CNS (Alzheimer’s disease) and oncology from Phase I to Phase III global pivotal studies. Dave graduated from Cornell ...

Ardian Latifi, PhD Dr Ardian Latifi, Clinical Development Manager at Que Oncology, has over 9 years of preclinical and clinical research experience. His

Use detailed technology terms.

Only spotfolio allows for searching with detailed technology terms, as we provide you with all topics that technology companies talk about.

Companies addressing these topics might be of specific interest to you, as they share more specific, niche topics.

Use Cases

Register now

Why Technology Scouting?

Technology scouting is the basis for your innovation management, identifies new technological developments as early as possible and protects you from disruptive business models.

Identify technology partners

Boost your market research

Look beyond major players

Build long and short lists

Collect technology leaders, providers, start ups and potential new partners in lists via simple tagging to take further steps with your team.